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Abstract
Background: Modified function of immune cells in nasal secretions may play a role in the enhanced susceptibility
to respiratory viruses that is seen in smokers. Innate immune cells in nasal secretions have largely been
characterized by cellular differentials using morphologic criteria alone, which have successfully identified
neutrophils as a significant cell population within nasal lavage fluid (NLF) cells. However, flow cytometry may be a
superior method to fully characterize NLF immune cells. We therefore characterized immune cells in NLF by flow
cytometry, determined the effects of live attenuated influenza virus (LAIV) on NLF and peripheral blood immune
cells, and compared responses in samples obtained from smokers and nonsmokers.
Methods: In a prospective observational study, we characterized immune cells in NLF of nonsmokers at baseline
using flow cytometry and immunohistochemistry. Nonsmokers and smokers were inoculated with LAIV on day 0
and serial nasal lavages were collected on days 1-4 and day 9 post-LAIV. LAIV-induced changes of NLF cells were
characterized using flow cytometry. Cell-free NLF was analyzed for immune mediators by bioassay. Peripheral blood
natural killer (NK) cells from nonsmokers and smokers at baseline were stimulated in vitro with LAIV followed by
flow cytometric and mediator analyses.
Results: CD45(+)CD56(-)CD16(+) neutrophils and CD45(+)CD56(+) NK cells comprised median 4.62% (range 0.33-
14.52) and 23.27% (18.29-33.97), respectively, of non-squamous NLF cells in nonsmokers at baseline. LAIV did not
induce changes in total NK cell or neutrophil percentages in either nonsmokers or smokers. Following LAIV
inoculation, CD16(+) NK cell percentages and granzyme B levels increased in nonsmokers, and these effects were
suppressed in smokers. LAIV inoculation enhanced expression of activating receptor NKG2D and chemokine
receptor CXCR3 on peripheral blood NK cells from both nonsmokers and smokers in vitro but did not induce
changes in CD16(+) NK cells or granzyme B activity in either group.
Conclusions: These data are the first to identify NK cells as a major immune cell type in the NLF cell population
and demonstrate that mucosal NK cell cytotoxic function is suppressed in smokers following LAIV. Altered NK cell
function in smokers suggests a potential mechanism that may enhance susceptibility to respiratory viruses.
Background
The nasal mucosa is the first site within the respiratory
system to be exposed to pollutants and inhaled viral
pathogens, including influenza. Therefore, nasal immune
cells are likely to play important roles in early innate
immune responses to these environmental stimuli.
While macrophages and dendritic cells (DC)s have been
identified in the nasal submucosa [1], and neutrophils
have been identified in the nasal cavity [2], the overall
immune cell populations within the nasal cavity have
not been fully characterized. To phenotype nasal lavage
fluid (NLF) cells, many researchers use cell differential
analysis of cytocentrifuge slides stained with hematoxy-
lin and eosin (H&E). Granulocytes are the easiest leuko-
cytes to identify with H&E staining due to their
polymorphic nuclei and are distinguished based on cyto-
plasmic staining: neutrophils have pale cytoplasm, eosi-
nophils have a red granular cytoplasm, and basophils
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have a purple granular cytoplasm [3]. T or B lympho-
cytes are smaller cells with dark, dense nuclei and little
cytoplasm [3]. Natural killer (NK) cells are larger lym-
phocytes with a pale cytoplasm and are difficult to dis-
tinguish due to a lack of specific cellular morphology. In
fact, NK cells appear similar to macrophages or mono-
cytes after H&E staining [3]. As a result, neutrophils,
basophils, and eosinophils, but not NK cells, have been
identified in NLF using cell differentials with H&E stain-
ing [4-6]. As an alternative to H&E staining, flow cyto-
metry can be used to positively identify leukocytes in
NLF. Flow cytometry has previously identified neutro-
phils in the NLF using CD16 expression [7,8] but
expression of CD56, the classical NK cell marker, has
not been used to positively identify NK cells in NLF.
However, flow cytometric analysis has positively identi-
fied CD56(+) NK cells as well as CD3(+) T lymphocytes
and HLA-DR(+) alveolar macrophages in the bronchoal-
veolar lavage of lung transplant recipients [9]. Thus, NK
cells have been identified in the airways of humans, [10]
but whether NK cells are present in the nasal cavity and
how they could function as a guard against inhaled pol-
lutants or pathogens is not known.
Influenza infection induces the recruitment of
immune cells into the lung, including NK cells [10]. NK
cells perform essential functions such as killing virus-
infected epithelial cells and secreting cytokines to regu-
late innate and adaptive immune responses [11]. CD16,
an FC receptor that induces antibody-dependent cell
mediated cytotoxicity [12], is classic marker identifying
neutrophils [13] but is also expressed on cytotoxic NK
cells [11]. CD16+ cytotoxic NK cells also have dim
CD56 expression and release cytotoxic granules contain-
ing perforin and granzymes to induce apoptosis in influ-
enza infected cells [14]. In contrast, CD16(-) NK cells
have bright CD56 expression and are considered “cyto-
kine-secreting” NK cells as they secrete IFNg that
matures dendritic cells (DCs) [14]. NK cell activation
during influenza infection is dependent upon secretion
of cytokines and chemokines such as “regulated upon
activation, normal T cell expressed and secreted”
(RANTES) and interferon gamma-induced protein 10
kDa (IP-10) from cells in the respiratory mucosa [15,16]
through binding to chemokine receptors CCR5 and
CXCR3, respectively. Upon activation by pathogens and
inflammatory mediators such as Type I IFNs, IL-12, and
IL-15, NK cells can become more cytotoxic as they
reduce CD56 expression and acquire CD16 expression
[17]. NK cells can also be activated by receptor
mediated interactions. NK cells express many activating
receptors, including NK cell activating receptor 2D
(NKG2D), which recognizes ligands induced during cel-
lular stress. As such, binding of ligands to the NKG2D
receptor on NK cells enhances NK cell cytokine
production as well as cytotoxic activity[16]. In this man-
ner, influenza infection in the respiratory tract may acti-
vate NK cells either through modification of activating
surface and chemokine receptors or enrichment of the
NK cell cytokine microenvironment. However, the role
of NK cells in antiviral responses to influenza infection
within the nasal passages has yet to be determined.
Airborne pollutants, such as cigarette smoke, have been
shown to increase susceptibility to respiratory viral infec-
tions, including influenza [18-20]]. We have recently
demonstrated that smokers’ nasal epithelial cells have
modified responses to influenza infections both in vivo
[2] and in vitro [21] resulting in increased markers of
influenza infection. Because NK cells can control and
regulate viral infections via killing of infected respiratory
epithelial cells, altered NK cell functions in smokers
could contribute to enhanced influenza infections.
Although smoking has been shown to suppress periph-
eral NK cell activity ex vivo [22-26], the effects of smok-
ing on respiratory NK cell functions are unknown [24].
Our goals were to 1) phenotype immune cells in the
nasal passages using flow cytometry, 2) determine the
presence and function of these cells in the context of a
viral infection, and 3) assess the effects of cigarette
smoke exposure on nasal immune cell function. Non-
smokers and smokers were inoculated with the live atte-
nuated influenza virus (LAIV) vaccine, similar to our
previous study [2]. Serial nasal lavages were used to
compare immune cell, and specifically NK cell, function
in the nasal cavity of smokers and nonsmokers. We also
compared peripheral blood NK cell responses to LAIV
in nonsmokers and smokers. Our results show that NK
cells are present in the NLF, NK cells in the NLF
change after inoculation with LAIV, and NK cell
responses are modified in smokers following LAIV.
Methods
Effect of LAIV on Nasal Immune Responses: Study Design
This was a prospective longitudinal study comparing
responses to LAIV between cohorts of healthy young
adult smokers and nonsmokers. The study design was as
described before [2]. Baseline measurements were done
at a screening visit and Day 0. On Day 0 subjects received
a standard nasal inoculum of the 2008-2009 formulation
of LAIV (FluMist®, MedImmune, Gaithersburg, MD;
administered by study nurse according to manufacturer’s
instructions) in both nostrils, then returned on Days 1, 2,
3, 4, and 9 post-LAIV for serial nasal lavages. Subject
exposure history questionnaires and urine cotinine levels
were used to estimate cigarette smoke exposure.
Study subjects
Subjects were identified as described before [2] and
included healthy young adults between 18-35 years old
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in two groups: Group 1 = nonsmokers not regularly
exposed to secondhand smoke (nonsmokers who neither
live nor work with active smokers) and Group 2 = self-
described active cigarette smokers. Informed consent
was obtained from all subjects and the protocol was
approved by the UNC Biomedical Institutional Review
Board. Exclusion criteria were as described before [2].
Table 1 details demographic and smoke exposure char-
acteristics of the subjects completing the study. Non-
smokers and smokers did not differ significantly for age,
BMI, or gender. One of 14 enrolled nonsmoker subjects
and 5 of 20 enrolled smoker subjects dropped out
before completion of the study. Two smoker nasal
lavage fluid sample sets were compromised by freezer
malfunction and therefore were not included in the ana-
lysis. Self-described smokers had significantly higher sec-
ondhand smoke exposure and urine cotinine values
compared to nonsmokers. No serious adverse events
occurred among subjects completing the protocol.
Nasal lavage
Nasal lavage was performed using a method we have
previously described [2,27]. In brief, 4 ml of saline was
sprayed into each nostril in 100 ul repetitive sprays fol-
lowed by periodic forceful expulsion of fluid into a col-
lection cup. Fluid from both nostrils was pooled. The
NLF was filtered using 40 μm cell strainer (BDBios-
ciences, San Jose, CA), and the NLF filtrate was pelleted
by centrifugation. Prior to dithiothreitol (DTT) treat-
ment, cell-free NLF was stored in aliquots at - 80°C
until used in mediator assays. Contents of the cell strai-
ner were treated with 1:20 DTT concentrate solution
(Sputolysin®, EMD Chemicals, Gibbstown, NJ) in HBSS.
Filtered cells were combined with DTT treated cells to
comprise the total NLF cell pellet. Cytocentrifuge slides
were stained for differential cell counts and immunohis-
tochemistry as described below The NLF cell pellet was
processed for flow cytometry as described below to
identify and quantify immune cells.
NLF Cell Differentials and Immunohistochemistry
Cytocentrifuge slides were prepared, fixed, and stained
using a modified Wright stain for differential cell
counts. For immunohistochemistry, cytocentrifuge slides
were fixed with ice-cold methanol, washed with TBS
and blocked with Powerblock (Biogenex, San Ramon,
CA) for 1 hr at room temperature. Slides were then
incubated with the following primary antibodies: mouse
anti-human CD56 antibody (MAB24081 RnD, Minnea-
polis, MN) or mouse anti-human perforin (BD Bios-
ciences) overnight at 4°C. The slides were washed with
TBS. Following incubation with an HRP (horse radish
peroxidase)-conjugated secondary antibody, samples
were washed with TBS and evaluated under light micro-
scopy. Nonspecific staining was assessed by omitting the
target-specific primary antibody. A full list of all antibo-
dies used for immunohistochemistry and flow cytometry
is located in Table 2.
Ex vivo NLF Cell Flow cytometry
The NLF cell pellet was suspended in flow cytometry
buffer (PBS, 0.09% sodium azide, 1% heat inactivated
FBS) and stained with antibodies to CD16 FITC (Beck-
man Coulter, Brea, CA), CD14 Pacific Blue (Biolegend,
San Diego, CA) CD56 PE, CD4 Pe-Cy5, CD3 PerCP,
CD45 APC-Cy7 (BD Biosciences) for 20 minutes at
room temperature in the dark. Cells were washed with
flow cytometry buffer, resuspended in 0.5% paraformal-
dehyde, and stored at 4°C in the dark. Samples were
acquired within 24 hrs on a BDLSRII flow cytometer
(BD Biosciences). Isotype-matched single color controls
were used to control for nonspecific staining and to set
analysis gates.
NLF mediator and urine cotinine assays
NLF granzyme B activity was measured using a Sensi-
Zyme Granzyme B Activity kit (Sigma, St. Louis, MO).
Urine cotinine was measured by ELISA (Bio-Quant, Inc.,
San Diego, CA) and expressed as a ratio to creatinine,
measured by a colorimetric assay (Oxford Biomedical
Research, Rochester Hills, MI).
In vitro NK Cell Stimulation Assays
Peripheral blood NK cells were isolated from peripheral
blood mononuclear cells (PBMC) from nonsmokers and
smokers at baseline and stimulated in vitro with the
2008-2009 strain of LAIV. PBMC were isolated from
nonsmokers and smokers using Lymphoprep™ (Axis-
Shield, Oslo, Norway). NK cells were isolated from
PBMC as described before [28] using the RosetteSep®
Human NK Cell Enrichment Cocktail (Stemcell,
Table 1 Subject characteristics and tobacco smoke
exposure
Nonsmoker
(n = 13)
Smoker
(n = 13)
Age (yr) 25.3 ± 1.0 23.5 ± 1.2
Gender 5M/8F 7M/6F
BMI 25.1 ± 1.3 28.2 ± 2.3
Daily exposure
Cigarettes smoked1 NA 8.5 ± 1.6
Urine cotinine2 0.0 ± 0.0 19.5 ± 7.1***
1 Data shown as mean ± SEM for cigarettes smoked. Data were averaged
from each subject’s self reported estimates for study days 0 through 9.
2 Data shown as mean ± SEM for mg cotinine (× 100)/mg creatinine. Data
were obtained using screen urine values.
*** P < .0001 vs. nonsmoker
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Vancouver, British Columbia). In brief, PBMC were
incubated with a 1:20 dilution of the antibody enrich-
ment cocktail in RPMI complete media [10% FBS, l-glu-
tamine (Invitrogen), and penicillin:streptomycin
(Invitrogen)] and washed red blood cells (RBC) in a
ratio of 100:1 RBC to PBMC. Cells were incubated at
room temperature for 20 minutes with gentle shaking.
Cells were washed with equal volume RPMI complete
media, layered on Lymphoprep™ gradient, and centri-
fuged at 800 g for 20 minutes at room temperature.
Non-NK PMBC pelleted with RBC and NK cells were
located in the interphase. Enriched NK cells were iso-
lated and washed with RPMI. 1 × 105 NK cells were sti-
mulated with 0.1 ul (2.56 HAU) LAIV (see below) in
100 ul of RPMI complete media for 24 h at 32°C in 5%
CO2. NK cells were centrifuged at 500 g for 5 min and
processed for flow cytometry as described below. Cell-
free supernatant was aliquoted and stored at -80°C for
assessment of granzyme B activity as described below.
LAIV propagation in MDCK cells in vitro
The 2008-2009 LAIV strain was propagated in Madin-
Darby Canine Kidney (MDCK) epithelial cells in vitro.
0.05 MOI LAIV stimulated 90% confluent MDCK cells
in serum free DMEM media supplemented with pen-
strep, l-glutamine and 0.2% trypsin without EDTA (all
Invitrogen) and incubated for 48 h at 32°C in 5% CO2.
The cell supernatant was gently aspirated and combined
with 10% fetal bovine serum (Invitrogen) to inactivate
trypsin. Cells and debris were pelleted by centrifugation
at 500 g for 10 minutes. Cell free supernatant was con-
centrated by centrifugation with an Amicon Ultra-15
Centrifugal Unit (Millipore, Billerica, MA) using a
100,000 molecular weight cutoff. Smaller proteins (cyto-
kines) fall through the filter whereas larger viruses
(LAIV) are collected. To generate a vehicle control,
MDCK cells were mock-infected with media and the
supernatant was processed in the same fashion. Concen-
trated LAIV was aliquoted and stored at -80°C until use.
LAIV was titered using a hemagglutination assay as
described before [29]. The titer for the propagated virus
was 25.6 HAU (hemagglutinin units)/ul, which was 8×
higher than the original 2008-2009 LAIV strain (data
not shown). MDCK-propagated LAIV was used in all in
vitro assays.
Peripheral NK Cell Flow Cytometry
NK cells were washed and resuspended in flow cytome-
try buffer and stained with antibodies to CD16 FITC
(Beckman Coulter), CD56 PE, CD3 APC-Cy7 (BD Bios-
ciences), CXCR3 and NKG2D (Biolegend) for 20 min-
utes at room temperature. Processing was completed as
described above in the ex vivo NLF flow cytometry
section.
Peripheral NK Cell Granzyme B Activity
Granzyme B activity from the in vitro LAIV NK cell sti-
mulation was quantified as described before [30]. Briefly,
NK cell supernatants were combined 1:1 with 50 mM
HEPES pH 7.5, 0.1% CHAPS, 10% sucrose, (all Sigma)
and 400 uM colorimetric granzyme B substrate I
(EMD4Biosciences, Merck, Darmstadt, Germany).
Supernatants were incubated at 37°C in 5% CO2 for 24
h. Absorbance was read using a plate reader at 405 nm
Table 2 Antibodies Used
Antibody [Reference] Isotype Control Dilution Company Clone Catalog Number
Anti-human CD56 [48] Mouse IgG2b,  1:100 RnD Systems 301021 MAB24081
Anti-human perforin [49] Mouse IgG2b,  1:100 BDBiosciences δG9 556434
APC anti-human NKG2D [50] Mouse IgG1,  1:10 Biolegend 1D11 320808
APC-Cy7 anti-human CD45 [51] Mouse IgG1,  1:20 BDBiosciences 2D1 557833
FITC anti-human CD16 [52] Mouse IgG1,  1:10 Beckman Coulter 3G8 IM0814U
Pacific Blue anti-human CD14 [53] Mouse IgG2a,  1:20 BDBiosciences M5E2 558121
PE anti-human CD56 [54] Mouse IgG1,  1:10 BDBiosciences B159 555516
PE-Cy5 anti-human CD4 [55] Mouse IgG1,  1:10 BDBiosciences RPA-T4 555348
PerCP anti-human CD3 [56] Mouse IgG1,  1:10 BDBiosciences SK7 347344
PerCP/Cy5.5 anti-human CXCR3[57] Mouse IgG1,  1:40 Biolegend TG1/CXCR3 334905
Biotinylated horse anti-
mouse IgG [58]
Horse 1:200 Vector Labs BA-2000
APC mouse IgG1,  1:100 BDBiosciences 555751
FITC mouse IgG1,  1:100 BDBiosciences 555748
Pacific Blue mouse IgG2a,  1:100 BDBiosciences 558118
PE mouse IgG1,  1:100 ebioscience 12-4714-81
PE-Cy5 mouse IgG1,  1:100 BDBiosciences 555750
PerCP mouse IgG1,  1:100 BDBiosciences 550672
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wavelength. A standard curve of granzyme B (Sigma)
with 1:1 serial dilutions was used to calculate specific
activity.
Statistical Analysis
Baseline differences between NLF cell populations were
determined using a Mann-Whitney U test. The effects
of smoking status on NLF responses to LAIV were ana-
lyzed using a Kruskal-Wallis One-way ANOVA followed
by Bonferroni’s posttest to determine differences on
individual days. An area under the curve (AUC) analysis
followed by a Kruskal-Wallis One-way ANOVA was
used as previously described [2] to determine the effects
of smoking status on total immune NLF responses to
LAIV. Within nonsmoker and smoker groups, Wilcoxon
matched pairs tests were used to determine the effects
of LAIV on peripheral NK cells in vitro. Data were
shown as mean ± SEM or median (interquartile range).
Results
Characterizing immune cells in NLF at baseline in
nonsmokers
A representative cellular differential of NLF cells was
pictured in Figure 1. Squamous cells (black arrows) in
the nasal lavage comprised 52.0% (37.3-62.5) of total
NLF cells in nonsmokers at baseline. Neutrophils
(dashed arrows) could also be identified by morphology
in the nasal lavage and comprise 7.7% (2.1-16.5) of non-
squamous NLF cells. We used flow cytometry to posi-
tively identify other non-squamous NLF cells. As shown
in Figure 2, forward scatter (FSC) and side scatter (SSC)
settings eliminated squamous epithelial cells from the
view. Negative expression of CD45, a marker that stains
only leukocytes, was used to discriminate between NLF
non-squamous epithelial cells and NLF leukocytes of
similar size. Figure 2 showed further analysis of CD45
(+) NLF cells stained for surface marker expression of
CD3 (T lymphocytes), CD4 (T helper lymphocyte)
CD14 (monocytes), CD16 (neutrophils), and CD56 (NK
cells). These data showed that of the markers tested,
only substantial subpopulations positive for CD16 and
CD56 were identified in CD45+ NLF cells.
To further characterize the immune phenotype of NLF
cells, we focused our analysis on CD16 and CD56. In
Figure 3A, a representative flow cytometric dot plot
showed CD16 and CD56 co-expression on CD45(+)
cells. Distinct CD56(+) NK cell (upper left quadrant)
and CD56(-)CD16(+) neutrophil (lower right quadrant)
populations were depicted. Also, CD16(-) NK cells
appeared to have “brighter” CD56 expression compared
to their CD56(+)CD16(+) NK cell counterparts. Figure
3B indicated that NK cells comprised a greater percen-
tage [23.3% (18.3-34.0)] compared to neutrophils [4.6%
(0.3-14.5)] of non-squamous NLF cells (p < 0.01). Per-
centages of cytokine-secreting CD16(-) NK cells [13.0%
(10.4-20.3)] were greater than percentages of cytotoxic
CD16(+) NK cells [8.8% (3.6-12.7)] in nonsmokers at
baseline as shown in Figure 3C (p < 0.05). None of the
CD45(+) leukocytes in the nasal lavage were CD3(+),
indicating that the CD56(+) cells were not natural killer
T (NKT) cells.
We used immunohistochemistry to confirm the pre-
sence of NK cells in the NLF. Positive immunohisto-
chemical staining for CD56 identified NK cells in Figure
4A. Cytotoxic NK cells were identified by immunohisto-
chemical staining for perforin, a cytotoxic granule
expressed in cytotoxic T lymphocytes and NK cells, as
shown in Figure 4B.
Comparison of smokers vs nonsmokers after LAIV
Smoker and nonsmoker groups did not differ by age,
BMI, or gender (Table 1). As expected, smokers had sig-
nificantly greater average urine cotinine levels than non-
smokers, indicating that the smokers continued to
actively smoke during the study period.
Using flow cytometry, percentages of NK cells and
neutrophils were quantified in the non-squamous NLF
cell population of nonsmokers and smokers before (Day
0) and after inoculation with LAIV (Days 1-4, 9). See
Figure 1 Nasal Lavage Cells . NLF cells from nonsmokers at
baseline were stained with hematoxylin and eosin. Squamous
epithelial cells (black arrows) and neutrophils (dashed arrows) can
be positively identified. n = 12. A representative image is shown.
Bar = 10 μm.
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Figure 2 Nasal Lavage Immune Cell Flow Cytometry. NLF cells were collected from nonsmokers at baseline and analyzed by flow cytometry
for leukocyte markers. The majority of NLF squamous epithelial cells are gated out by FSC and SSC settings. CD45+ NLF leukocytes are identified
in NLF cells. CD45+ NLF cells (P1) are negative for surface markers CD3 (T lymphocytes) CD4 (Helper T lymphocytes), and CD14 (monocytes).
CD45+ NLF cells contained populations positive for CD16 (neutrophils, NK cells, P2) and CD56 (NK cells, P3). A representative image at baseline is
shown. Open histograms: isotype matched control, P1. Shaded histograms: surface markers, P1.
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schematic in Figure 5. There were no statistically signifi-
cant differences in total NK cell percentages associated
with either LAIV or smoking status (see Figure 6A).
Total neutrophil percentages were also similar between
groups and unchanged after LAIV (Figure 6B), which
confirms our previous observations [2]. To further char-
acterize NK phenotypes after LAIV, proportions of cyto-
toxic NK cells within the total NK cell population were
determined by assessing CD16(+) expression on NK
cells using flow cytometry and cytotoxic NK cell activity
was determined by measuring granzyme B bioactivity in
the NLF. CD16(+) NK cells increased by day 2 after
LAIV in nonsmokers, but this increase was significantly
blunted in smokers (Figure 7A). Similarly, the rise in
granzyme B seen in nonsmokers by day 3 was signifi-
cantly suppressed in smokers (Figure 7B); as well as an
overall suppression of granzyme B response post LAIV
in smokers, albeit not statistically significant (p = 0.09,
Table 3).
Figure 3 Characterization of NK Cells in the Nasal Lavage by
Flow Cytometry. NK cells were identified in CD45+ NLF cell
populations of nonsmokers at baseline. A) Representative flow
cytometric plot depicting NK cells (CD56+) and neutrophils (CD56-
CD16+). B) Percentages of total NK cells are greater than neutrophils
in non-squamous NLF cell populations. C) Percentages of CD16- NK
cells are greater than percentages of CD16+ NK cells in non-
squamous NLF cell populations. **p < 0.01, * p < 0.05. Nonsmoker
n = 11.
Figure 4 Characterization of NK cells in the Nasal Lavage by
Immunohistochemistry. NLF cells were characterized using
immunohistochemistry. A) NLF cells are stained with anti-CD56-HRP
to identify NK cells and B) NLF cells are stained with anti-perforin-
HRP to identify cytotoxic NK cells. Bar = 10 μm.
Figure 5 Schematic of LAIV Study Design. Nonsmokers and
smokers were given a baseline nasal lavage followed by inoculation
with LAIV on Day 0. Serial nasal lavages were obtained on Days 1-4
and again on Day 9. Urine was collected throughout to study to
measure cotinine, a metabolite of nicotine, as a marker of cigarette
smoke exposure.
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To determine whether the effects of cigarette smoke
exposure on NK cell function are evident systemically,
peripheral blood NK cells were isolated from nonsmo-
kers and smokers and stimulated in vitro with LAIV.
Preliminary studies indicated that peripheral blood NK
cells were CD45(+), as expected, so we excluded this
marker from further analysis (data not shown).
Percentages of peripheral cytotoxic CD16(+) NK cells
were not altered by in vitro stimulation with LAIV in
either nonsmokers or smokers (Figure 8A). Interestingly,
peripheral blood cytotoxic CD16(+) NK cells composed
a larger proportion of total NK cells [84.2% (79.3-90.4)]
(Figure 8A) versus mucosal NK cell populations [28.3%
(22.2-46.2)] in nonsmokers at baseline (Figure 7A) (p <
0.0001). LAIV did not induce granzyme B secretion in
peripheral NK cells from smokers or nonsmokers (Fig-
ure 8B). To determine if LAIV stimulation in vitro can
alter expression of peripheral NK cell activating and
chemokine receptors (NKG2D and CXCR3), we assessed
receptor expression by flow cytometry. LAIV increased
NKG2D (Figure 8C) and CXCR3 (Figure 8D) expression
on peripheral NK cells from both nonsmokers and smo-
kers. However, there were no differences in peripheral
Figure 6 LAIV Does Not Significantly Affect Total NK Cell or
Neutrophil Percentages in Nonsmokers or Smokers. Using flow
cytometry we identified NK cells and neutrophils in nonsmoker and
smoker non-squamous NLF cells after LAIV inoculation. Neither A)
NK cell nor B) neutrophil percentages in total NLF cells change
following LAIV in either group. Nonsmokers n = 12 (■, solid line),
smokers n = 9 (▲, dashed line).
Figure 7 Cytotoxic NK Cell Activity is Suppressed in Smokers
Following LAIV. Cytotoxic NK cell percentages and activity were
analyzed in NLF of nonsmokers and smokers after LAIV inoculation.
A) CD16+ cytotoxic NK cell percentages of total NK cells were
decreased in the NLF of smokers following LAIV. Kruskal-Wallis p =
0.09, *p < 0.05 nonsmoker vs smoker posttest. Nonsmokers n = 12
(■, solid line), smokers n = 9 (▲, dashed line). B) Granzyme B activity
was decreased in NLF of smokers following LAIV inoculation.
Kruskal-Wallis p < 0.01, *p < 0.05 nonsmoker vs smoker post-test.
Nonsmokers n = 13 (■, solid line), smokers n = 13 (▲, dashed line).
Table 3 Total NLF granzyme B responses post LAIV
Nonsmokers
(N = 13)
Smokers
(N = 13)
P (Kruskal-Wallis)
Granzyme B 225.0
(68.7-519.3)
111.5
(14.9-310.0)
0.09
Data are shown as median (interquartile range). Area under NLF mediator
quantity, Day 1-9 after LAIV inoculation.
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NK cell receptor expression between smokers and
nonsmokers.
Discussion
Characterizing innate immune cells within the nasal pas-
sages is an important step in understanding how pre-
existing conditions, such as smoking, affect anti-influenza
responses in the respiratory epithelium. Using a model of
in vivo human influenza infection [2] and ex vivo flow
cytometric methodology, we observed that 1) NK cells
are present in nasal secretions and constitute a significant
portion of NLF immune cells, 2) the “normal” nasal NK
cell response to LAIV involves an increase in activated
cytotoxic NK cells, and 3) these LAIV-induced cytotoxic
NK cell responses in are suppressed in smokers.
The identification of NK cells as a prominent immune
cell type in NLF is, to our knowledge, a novel finding
and suggests that the study of innate immune responses
in the upper airways should take NK cells into account.
The use of cell differentials alone to phenotype NLF
cells has likely overlooked NK cells [4-6]. As shown in
Figure 4, NK cells have non-descript morphologies and
could be mistaken for NLF monocytes, macrophages or
even basal epithelial cells. Using flow cytometry, other
researchers have identified CD16(+) NLF cells. However,
these CD16(+) cells were either classified as neutrophils
[7] or the analysis gate was based on the relative size of
a lymphocyte population [8], thus likely excluding NK
cells. In our study, activated NK cells in NLF appeared
to be of similar size and granularity as neutrophils as
evidenced by the flow cytometric CD56 staining and
SSC properties (see Figure 2). This is not surprising as
both NK cells and neutrophils contain cytotoxic gran-
ules that should influence their SSC fluorescence. Figure
Figure 8 Effect of LAIV On Peripheral NK Cell Activity. Peripheral blood NK cells were isolated from nonsmokers and smokers and stimulated
in vitro with LAIV. LAIV did not increase A) percent CD16+ cytotoxic NK cells or B) granzyme b activity in either nonsmokers or smokers. LAIV
increased expression of C) NK cell activation receptor NKG2D and D) chemokine receptor CXCR3 in both nonsmokers and smokers. Nonsmokers
n = 6 (black bars), smokers n = 6 (white bars). *** p < 0.001 vs vehicle control.
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4 shows that NK cells positively identified in the NLF
using immunohistochemistry are relatively large cells
compared to T lymphocytes [3] and have significantly
greater cytoplasm/nucleus ratio. In addition, CD56 is
essential to positively identify NK cells. A previous
report did not observe any CD56(+) NK cells in NLF
[31], but these studies used a significantly different
study population (allergic rhinitics) and were focused on
IL-4 producing lymphocytes, not NK cells, within the
NLF [31]. In addition, they, as well as others [5-8], per-
form nasal lavages by administering a single bolus dose
of saline which is held in the nasal cavity and then pas-
sively expelled [31]. This is in contrast to our method,
which uses repetitive spraying of smaller volumes of sal-
ine followed by forceful expulsion and collection. We
speculate that compared to the bolus method of NLF
collection, our method may be more mechanically dis-
ruptive to the nasal mucosa and thus produces higher
numbers of NLF immune cells. However, in the NLF
analyzed here, neutrophils, characterized both by cellular
differential and flow cytometry analysis, were at levels
similar to what has been described in bolus nasal lavages
of normal human subjects at baseline by cell differential
analysis [32].
Our data also show that NLF NK cells are activated
during an influenza infection in healthy nonsmokers.
Multiple signals contribute to NK cell activation includ-
ing direct engagement of NK cell activating receptors by
influenza virus [33], autocrine stimulation by activated
NK cell derived chemokines [15,34], and paracrine stimu-
lation by other immune cells like DCs [35,36]. Therefore,
NK cell activation is in part dependent on communica-
tion with other cell types. We have shown here that
LAIV increases cytotoxic CD16(+) NK cell percentages
and granzyme B activity in the NLF of nonsmokers, but
did not observe similar increases in peripheral NK cells
alone. This suggests that in the setting of infection, che-
mokines and mediators released by other cells within the
nasal mucosa assist in activating and maturing NK cells.
We have previously shown that influenza-induced IP-10
levels are reduced in the nasal epithelium of smokers
both in vivo [2] and ex vivo [37]. IP-10 secreted from the
nasal epithelium can induce chemotaxis and enhance
cytotoxic activity in resting NK cells [15], suggesting that
a decrease in IP-10 levels in the context of a viral infec-
tion may lead to the suppressed NK cell cytotoxic
responses demonstrated here. Tobacco smoke-induced
decreases in activating cytokines such as IP-10 could cre-
ate a microenvironment unfavorable for NK cell matura-
tion resulting in suppressed CD16(+) NK cell
percentages, granzyme B activity, and suppression of
IFNg in the NLF, which we have shown previously [2].
Our data suggest that peripheral NK cell responses are
not affected by smoking status. CD56bright CD16(-)
cytokine-secreting NK cells predominate in lymph nodes
and mucosal tissues, whereas CD56dim CD16(+) cyto-
toxic NK cells are found in higher percentages in the
peripheral blood [10]. Because total NK cell percentages
in NLF did not change following LAIV in either non-
smokers or smokers in our study, it is possible that the
cytokine milieu within the nasal mucosa induced NK
cell switching from a cytokine secreting to a cytotoxic
phenotype [38]. We did not observe this class switching
in peripheral NK cells inoculated with LAIV, which may
be due to either differences in NK cell phenotypes or
the lack of maturation cytokines from exogenous
immune and respiratory cells present in the nasal
mucosa. In addition, while stimulation with LAIV ex
vivo did enhance activation markers NKG2D and
CXCR3 on peripheral blood NK cells in both nonsmo-
kers and smokers, LAIV did not induce granzyme B
bioactivity in peripheral NK cells ex vivo in either group.
It is possible that peripheral and mucosal NK cell phe-
notypes and responses are distinct and that NK cells
require a combination of signals derived from direct
infection and exposure to a maturation cytokine mixture
to become fully activated and secrete cytotoxic gran-
zymes. However, differences between in vivo and in
vitro LAIV inoculation procedures could account for the
disparate responses between mucosal and peripheral
blood NK cells. In vivo, LAIV infects multiple cell types
including nasal epithelial cells and neutrophils in addi-
tion to NK cells. LAIV inoculation procedures in vivo
also differ with respect to dose and timing compared to
the in vitro inoculation. Thus although there appear to
be differences between peripheral and mucosal NK cell
responses, limitations in the in vitro study design could
impact these conclusions.
Smokers are prone to respiratory microbial and viral
infections, including pneumococcal pneumonia, legionel-
losis, meningococcal disease, rhinovirus, and influenza
virus [39]. We have shown here that smokers have
decreased NK cell activity in the nasal passage, and this
lack of functional NK cells patrolling the upper airways
may contribute to increased respiratory infections. A
potential limitation of the NLF data shown here are the
subtle yet statistically significant magnitude of differ-
ences in responses between nonsmokers and smokers.
However, considering the interplay NK cells have with
other cells of the respiratory mucosa (epithelial cells,
dendritic cells), it is likely that changes in NK cell activ-
ity that appear subtle based on magnitudes of the
experimental parameters could have a significant impact
on overall mucosal immune responses. Interestingly,
decreased NK cell cytotoxicity may also play a role in
tumorigenesis in the respiratory system [40]. NK cells
from smokers have decreased anti-tumor action in vitro
[41], and decreased peripheral lymphocyte cytotoxicity
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in vitro is associated with increased cancer risk [42].
Thus, enhancement of NK cell function against infected
cells or tumors could be an important therapeutic strat-
egy for both smokers and cancer patients. For cancer
patients, several NK cell therapies are already in clinical
trials [43]. Adiponectin treatment of NK cells exposed
to cigarette smoke in vitro partially restores NK cell
cytotoxicity, suggesting that adiponectin may be an
intriguing candidate for NK cell enhancement [44].
Thus, suppressed NK cell activity in the nasal secretions
of smokers may contribute to the suppressed anti-viral
and anti-tumor function seen in the respiratory tracts of
smokers.
NK cells in the nasal secretions may play important
roles in nasal immunity through control of respiratory
viral infections both in normal individuals and those
with underlying respiratory conditions. Viral infections
and inflammation within the nasal passages could affect
immune responses in the lower airways, especially in
individuals with underlying lower airway disease such as
chronic obstructive pulmonary disease (COPD) or
asthma. COPD is also associated with nasal inflamma-
tion and blockage of the upper airways [45]. In asth-
matic individuals, treatment of rhinitis and sinusitis
improves asthma disease symptoms [46], indicating that
nasal inflammation can affect asthma symptoms. Infec-
tions with viruses such as human rhinovirus are a major
cause of both COPD and asthma exacerbations and the
majority of these infections originate in the nose [47].
Thus, innate immune cells, particularly NK cells, could
play important roles in controlling viral infections and
inflammation within the nose and prevent worsening of
preexisting respiratory conditions.
Conclusions
In summary, we have demonstrated that NK cells are
present in nasal secretions. NK cells could play an
important role in nasal innate immunity to viruses, as
well as in the suppressed immune responses to respira-
tory infection seen in smokers. Further study of this
unique mucosal immune cell population will be benefi-
cial in assessing the effects of both pollutants and patho-
gens on upper respiratory immune responses in healthy
and diseased populations.
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